The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study

BACKGROUND: The 5-year survival rate of patients with locally advanced esophageal cancer is still low after neoadjuvant therapy plus esophagectomy, and additional adjuvant treatment may be required. Some studies have shown that patients can still benefit from adjuvant chemotherapy (AC) despite its t...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Hongbo, Zhang, Peng, Li, Feng, Liu, Donglei, Wu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830371/
https://www.ncbi.nlm.nih.gov/pubmed/36636082
http://dx.doi.org/10.21037/jgo-22-1008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830371/
https://www.ncbi.nlm.nih.gov/pubmed/36636082
http://dx.doi.org/10.21037/jgo-22-1008

Ejemplares similares